Nonagenarians Stay Active

But this is a false assumption in the case of Reichstein, who at age 95 is still publishing. Reichstein, who shared the 1950 Nobel Prize in physiology or medicine for discoveries relating to the hormones of the adrenal cortex, is still hard at work at the Institute of Organic Chemistry at the University of Basel, Switzerland, actively participating in international collaborations. His 1992 paper "The phloroglucinols of Dryopteris s

Written bySteven Benowitz
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

But this is a false assumption in the case of Reichstein, who at age 95 is still publishing. Reichstein, who shared the 1950 Nobel Prize in physiology or medicine for discoveries relating to the hormones of the adrenal cortex, is still hard at work at the Institute of Organic Chemistry at the University of Basel, Switzerland, actively participating in international collaborations.

His 1992 paper "The phloroglucinols of Dryopteris stenolepis" (C.J. Widen, P. Ayras, T. Reichstein, Annales Botancici Fennici, 29[1]:41-54), for example, was coauthored with Finnish researchers from the University of Helsinki and the University of Turku. In the United States, a change in a federal law may make nonagenerian researchers like Reichstein more common on university campuses. January 1 of this year marked the end of the exemption for university faculty to the Age Discrimination in Employment Act, which in essence will prohibit mandatory retirement for professors (see story on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies